Latest news from SABCS 2025
-
View from the Trenches panelists place SABCS presentations into clinical context
Experts wrapped up the 2025 San Antonio Breast Cancer Symposium by discussing how to translate the week’s presentations into immediate impact for patients and physicians.
-
Special session explores key distinctions, considerations around breast cancer in young women
Panelists reviewed the biological features, treatment decisions, and ethical nuances around young-onset breast cancer.
-
Plenary lecturer reviews work to enhance understanding of BRCA1/2-mediated tumorigenesis
Joan Brugge, PhD, shared new insights into breast tumorigenesis in BRCA1/2-mutation carriers.
-
AACR Distinguished Lectureship recipient shares goals for future applications of ctDNA detection
Ben Ho Park, MD, PhD, discussed the potential of circulating tumor DNA (ctDNA) to transform adjuvant treatment for breast cancer.
-
Experts highlight alcohol use and obesity as risk factors of breast cancer
Panelists examined the latest understanding about the connections between breast cancer and lifestyle factors, such as alcohol consumption and obesity.
-
Special session amplifies dialogue on lobular breast cancer
Presenters explored topics related to lobular breast cancer, including ILC-specific considerations for clinical trials, diagnostic criteria, and the role of adjuvant chemotherapy.
-
Second General Session reveals findings from de-escalation trials, preoperative radiotherapy study, and more
Gaorav Gupta, MD, PhD; Isabelle Bedrosian, MD; and Marjolein Smidt, MD, PhD, were among the experts reporting findings Thursday during the General Session at the San Antonio Breast Cancer Symposium.
